Branchburg, NJ, United States of America

Jian Wang

This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Lycera Corporation. Active years: 2016-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jian Wang. Retrieved from https://idiyas.com/inventor/jian-wang-26g6gvvu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2016-2018

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jian Wang

Introduction

Jian Wang is a notable inventor based in Banchburg, NJ (US). He has made significant contributions to the field of medical therapeutics, holding a total of 3 patents. His work focuses on developing compounds that have the potential to treat various medical disorders.

Latest Patents

Among his latest patents, Jian Wang has developed trifluoromethyl pyrazolyl guanidine compounds that inhibit FF-ATPase. These compounds are designed to be used as therapeutic agents for treating medical disorders, including immune disorders, inflammatory conditions, and cancer. This innovative approach highlights his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Jian Wang is currently associated with Lycera Corporation, where he continues to push the boundaries of medical research. His work at the company emphasizes the importance of developing new therapeutic agents that can address unmet medical needs.

Collaborations

Jian has collaborated with several talented individuals in his field, including Alexander Ross Hurd and Clarke Bentley Taylor. These collaborations have likely contributed to the innovative nature of his work and the successful development of his patents.

Conclusion

Jian Wang's contributions to the field of medical therapeutics through his patents and work at Lycera Corporation demonstrate his dedication to innovation and improving healthcare solutions. His ongoing research and collaborations are expected to yield further advancements in the treatment of serious medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…